Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
CRNX holding history
Crinetics Pharmaceuticals, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −2,210,774−100.0% | Sold out | Holders |
| Q4 2025 | 2,210,774 | $102.9M | 2.8% | −340,000−13.3% | Reduced | Holders |
| Q3 2025 | 2,550,774 | $106.2M | 3.1% | +207,221+8.8% | Added | Holders |
| Q2 2025 | 2,343,553 | $67.4M | 2.9% | +397,385+20.4% | Added | Holders |
| Q1 2025 | 1,946,168 | $65.3M | 3.0% | +35,407+1.9% | Added | Holders |
| Q4 2024 | 1,910,761 | $97.7M | 3.4% | −605,925−24.1% | Reduced | Holders |
| Q3 2024 | 2,516,686 | $128.6M | 4.5% | +3,384+0.1% | Added | Holders |
| Q2 2024 | 2,513,302 | $112.6M | 4.3% | −611,447−19.6% | Reduced | Holders |
| Q1 2024 | 3,124,749 | $146.3M | 5.1% | +811,830+35.1% | Added | Holders |
| Q4 2023 | 2,312,919 | $82.3M | 3.9% | +134,182+6.2% | Added | Holders |
| Q3 2023 | 2,178,737 | $64.8M | 4.4% | +783,735+56.2% | Added | Holders |
| Q2 2023 | 1,395,002 | $25.1M | 2.0% | +261,220+23.0% | Added | Holders |
| Q1 2023 | 1,133,782 | $18.2M | 1.7% | +243,677+27.4% | Added | Holders |
| Q4 2022 | 890,105 | $16.3M | 1.9% | +370,849+71.4% | Added | Holders |
| Q3 2022 | 519,256 | $10.2M | 1.4% | +519,256 | New | Holders |